ClinicalTrials.gg
Drug

Tradipitant clinical trials

Also written VLY-686 and LY686017.

studies test it
21
open now
3
in phase 3
9
first study started
2004

How each study uses tradipitant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tradipitant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Dec 2025 · NEREUS · NDA 220152 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tradipitant
15

Brand

Nereus
1

Development codes

VLY-686
3
LY686017
3

Studies by the year they started

21 studies that test it; most in 2023 (3)

Studies that test tradipitant, by start year
YearStudies
20041
20061
20081
20132
20151
20162
20182
20192
20201
20212
20233
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
10
Phase 3
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 2

Vanda Pharmaceuticals (17) · Eli Lilly and Company (2) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · Xiao Jing (Iris) Wang (1)

Often tested with

Tested in the same studies.

Midazolam (1) · Paroxetine (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 2 in phase 3

Studies that test tradipitant, phase 3 first.

Studies

Open first, then newest update. How each study uses tradipitant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test tradipitant →

Codes

What other systems call tradipitant · ClinicalTrials.gg INT002158

  • MeSH (NLM) C000731911tradipitantOne source NLM
  • UNII (FDA) NY0COC51FITRADIPITANTConfirmed FDA, NLM, Wikidata
  • Wikidata Q1798493tradipitantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152707TradipitantOne source FDA
  • DrugBank DB12580One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.